Training for SafeScript


Pharmacist using computer

When the system launches in October this year, Victorian prescribers and pharmacists will have access to information regarding the history and usage of drugs of abuse

SafeScript, the Victorian Government’s initiative that provides for real-time prescription monitoring of certain medicines that are prone to abuse and misadventure, will be available to clinicians from October.

After an introductory period of 18 months, the use of SafeScript when prescribing and dispensing monitored medicines will become mandatory.

Medicines that have been selected for monitoring through SafeScript include:

  • All Schedule 8 medicines including drugs used in the Opioid Replacement Therapy (ORT) program;
  • Zopiclone;
  • Zolpidem;
  • Quetiapine;
  • Benzodiazepines; and
  • Schedule 4 codeine combinations.

PDL has encouraged pharmacists to complete training for SafeScript, which will include advice on non-pharmacological treatment options and engaging in conversations with patients when you have concerns about their safety.

Pharmacists in the Western Victoria Primary Health Network (WVPHN) region can now register for SafeScript and enrol in SafeScript training, says PDL.

The WVPHN region will be the initial focus, with roll out to the rest of Victoria in early 2019.

To complete the registration process, pharmacists will be emailed a link to their email address registered with AHPRA or can register here from mid-August. A dedicated IT support line will be available to assist you with registration.

Pharmacists are strongly encouraged to take advantage of comprehensive online SafeScript training, attracting CPD points.

Three training modules will cover safe supply of high-risk medicines, using respectful communication to discuss medicine dependence, as well as how to use SafeScript.

Additional face-to-face training will also be delivered by WVPHN later this year.

PDL reminds pharmacists that in conjunction with SafeScript, they should continue to:

  • Always contact the prescriber if there are any concerns about the safety of a prescription.
  • Consider the safest and most appropriate treatment approach for the consumer, which may include referral back to the prescriber, or supplying limited quantities until the consumer can be reviewed.
  • Document the agreed course of action.
  • Discuss with your patient your concerns about their safety.

As part of SafeScript implementation, a help line will be available for patients experiencing prescription medicine dependency.

Call 1300 854 838 if this topic raises any concerns for you. PDL membership includes 24/7 access to speak with a Professional Officer for immediate advice and incident support, Australia wide.

Previous Prednisolone, methadone errors
Next Our concerns about clinical pharmacy funding

NOTICE: It can sometimes take awhile for comment submissions to go through, please be patient.